Glory Health Industry Limited (2329.HK)
HKD 0.04
(21.21%)
HKD 0.04
(21.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -484.56 Million CNY | -16.73% |
| 2022 | -415.13 Million CNY | -183.69% |
| 2021 | 496.01 Million CNY | 107.45% |
| 2020 | 239.1 Million CNY | -81.25% |
| 2019 | 1.27 Billion CNY | -32.32% |
| 2018 | 1.88 Billion CNY | -27.88% |
| 2017 | 2.61 Billion CNY | 3.37% |
| 2016 | 2.52 Billion CNY | 21.9% |
| 2015 | 2.07 Billion CNY | 6.33% |
| 2014 | 1.95 Billion CNY | -40.5% |
| 2013 | 3.27 Billion CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q4 | -398.71 Million CNY | -364.42% |
| 2023 Q2 | -85.85 Million CNY | -235.17% |
| 2023 FY | -484.56 Million CNY | -16.73% |
| 2022 Q2 | -478.64 Million CNY | -84.95% |
| 2022 Q4 | 63.51 Million CNY | 113.27% |
| 2022 FY | -415.13 Million CNY | -183.69% |
| 2021 Q2 | 754.82 Million CNY | 409.88% |
| 2021 FY | 496.01 Million CNY | 107.45% |
| 2021 Q4 | -258.8 Million CNY | -134.29% |
| 2020 Q4 | -243.58 Million CNY | -150.46% |
| 2020 FY | 239.1 Million CNY | -81.25% |
| 2020 Q2 | 482.68 Million CNY | -23.82% |
| 2019 Q2 | 641.93 Million CNY | -54.61% |
| 2019 Q4 | 633.57 Million CNY | -1.3% |
| 2019 FY | 1.27 Billion CNY | -32.32% |
| 2018 Q4 | 1.41 Billion CNY | 200.58% |
| 2018 FY | 1.88 Billion CNY | -27.88% |
| 2018 Q2 | 470.46 Million CNY | -75.23% |
| 2017 Q2 | 713.66 Million CNY | -45.1% |
| 2017 FY | 2.61 Billion CNY | 3.37% |
| 2017 Q4 | 1.89 Billion CNY | 166.18% |
| 2016 FY | 2.52 Billion CNY | 21.9% |
| 2016 Q2 | 1.22 Billion CNY | 19.07% |
| 2016 Q4 | 1.29 Billion CNY | 5.83% |
| 2015 Q4 | 1.03 Billion CNY | -1.05% |
| 2015 Q2 | 1.04 Billion CNY | -15.8% |
| 2015 FY | 2.07 Billion CNY | 6.33% |
| 2014 Q4 | 1.23 Billion CNY | 73.79% |
| 2014 Q2 | 712.37 Million CNY | -40.23% |
| 2014 FY | 1.95 Billion CNY | -40.5% |
| 2013 Q4 | 1.19 Billion CNY | -42.87% |
| 2013 FY | 3.27 Billion CNY | 0.0% |
| 2013 Q2 | 2.08 Billion CNY | 134.91% |
| 2012 Q4 | 887.99 Million CNY | 0.0% |